Adam received his Ph.D. from the Department of Anatomy and Cell Biology at the University of Melbourne (Australia) working with Dr. Brian Key on the role of cell-surface carbohydrates in axon guidance within the olfactory system. He then moved to the U.S. to conduct post-doctoral work with Dr. Michael T. Shipley at the University of Maryland. He remained at the University of Maryland School of Medicine as tenured faculty in the Department of Anatomy and Neurobiology.

Sarah L.J. Michel, PhD, began her tenure as dean of the University of Maryland School of Pharmacy (UMSOP) on Oct. 15, 2023.Michel is a professor, former chair of UMSOP’s Department of Pharmaceutical Sciences (PSC), former associate dean for graduate programs, and an internationally recognized leader in the field of metals in medicine. Her work has been funded by the National Institutes of Health (NIH), the National Science Foundation (NSF), and U.S. Army Research labs for investigating the roles that metals play in the regulation of chronic inflammation, cancer, and neurodegenerative diseases.She also has been active in clinical research through Food and Drug Administration (FDA) grants, and she has been closely involved with the Maryland Center of Excellence in Regulatory Science and Innovation. Notably, a FDA clinical trial headed by Michel led the FDA to issue new guidance on how generic nanomedicines should be evaluated for approval. In addition, she is part of a PSC and University of Maryland School of Dentistry team of researchers funded by the FDA that is investigating the safety of electronic cigarettes.In her nearly 19 years at UMSOP, Michel has been intricately involved in all of the school’s educational aspects, including PhD and MS programs and the Doctor of Pharmacy (PharmD) program, where she redesigned the core biochemistry course to emphasize clinical applications to pharmacy and led the development of the PharmD research pathway. She has mentored dozens of PhD and PharmD students and has a keen understanding of the pharmacy profession, as well as the many roles and career opportunities for today’s UMSOP students.Michel received a bachelor’s degree in chemistry from Cornell University and a PhD in chemistry from Northwestern University. She completed an NIH National Research Service Award postdoctoral fellowship at the Johns Hopkins University School of Medicine.For interview requests, please contact the Office of Communications and Public Affairs: https://www.umaryland.edu/news/for-the-media/

Diane Forbes Berthoud is the University of Maryland, Baltimore’s (UMB) first chief equity, diversity, and inclusion officer and vice president (CEDIO/VP), assuming the role July 1, 2021.As CEDIO/VP, she reports directly to UMB’s president and leads and advances the University’s equity, diversity, and inclusion (EDI) strategy, implementation, and accountability. She oversees institutional change necessary for deepening and strengthening the university's commitment to EDI, and designs and operationalizes a transparent accountability framework to measure and evaluate the impact and effectiveness of UMB’s EDI initiatives at every level of the institution.

Mathew Swinburne is the associate director for the Network for Public Health Law’s Eastern Region, which is housed at the University of Maryland Francis King Carey School of Law.He brings more than 14 years of legal experience and specifically more than 10 years of public health law experience. He is a recognized national expert in cannabis law and policy.His cannabis work includes advising legislators, state and local agencies, law enforcement, community-based organizations, and non-profits on critical issues related to medical and adult-use policy.In addition to his work at the Network for Public Health Law, he developed and taught the State and Federal Cannabis Law and Policy course for the University of Maryland School of Pharmacy’s MS in Medical Cannabis Science and Therapeutics Program.

Leah Sera is the associate dean for recruitment and admissions at UMSOP. She is an associate professor and vice chair for academic affairs in the Department of Practice, Sciences, and Health Outcomes Research. She is a board-certified pharmacotherapy specialist, and her clinical specialties are pain management and palliative care.Additionally, Dr. Sera holds an associate faculty position at the University of Maryland Graduate School.Dr. Sera was the inaugural program director for the nation’s first Graduate Studies in Medical Cannabis program at UMSOP, which includes the MS in Medical Cannabis Science and Therapeutics (MCST) and Graduate Certificate in Medical Cannabis Science, Therapeutics, and Policy.Dr. Sera teaches several courses in the MCST program, including an introduction to medical cannabis history, culture, and policy and a course introducing students to evidence-based medicine and the clinical uses of medical cannabis; she also mentors students in their capstone projects. Dr. Sera teaches a variety of topics in required and elective courses in the Doctor of Pharmacy curriculum.

A signing ceremony on Jan. 10, 2025, marked the announcement of a $10 million joint gift from Edward and Jennifer St. John and the Edward St. John Foundation, which will establish the Edward & Jennifer St. John Center for Translational Engineering and Medicine (CTEM).The new center brings together researchers from the University of Maryland School of Medicine (UMSOM) at UMB and the A. James Clark School of Engineering at the University of Maryland, College Park (UMCP). Occupying the fourth floor of 4MLK at the University of Maryland BioPark, CTEM will foster face-to-face collaboration among clinicians and engineers.Their proximity will ensure that real-world clinical needs inform the creation of new devices, diagnostics, and treatments, accelerating the pathway from research to patient care – resulting in next-generation medical solutions that will benefit patients across Maryland and beyond.Read More: https://www.umaryland.edu/news/archived-news/january-2025/10m-gift-to-power-innovations-for-next-gen-care.php